By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Naurex Inc. 

1801 Maple Avenue
Suite 4300
Evanston  Illinois  60201  U.S.A.
Phone: 317-250-3276 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Allergan (AGN) Coughs Up $560 Million Cash for Naurex 7/27/2015 5:50:59 AM
Naurex Inc. To Present Clinical Data For NRX-1074 At 2015 American Society Of Clinical Psychopharmacology Annual Meeting 6/22/2015 12:42:38 PM
Naurex Inc. To Present Preclinical And Clinical Data For NRX-1074 And Rapastinel At Upcoming Scientific Meetings 5/12/2015 10:23:11 AM
Naurex Inc. To Present At 22nd Annual BioCentury Future Leaders In The Biotech Industry Conference 3/16/2015 9:30:58 AM
Naurex Inc.'s First Orally Active Molecule, NRX-1074, Demonstrates Statistically Significant Improvement In Depression Scores Within 24 Hours In Phase 2 Study For Major Depressive Disorder 1/27/2015 7:28:28 AM
Naurex Inc. To Present At 33rd Annual J.P. Morgan Healthcare Conference 12/19/2014 9:46:09 AM
Naurex Inc.'s GLYX-13 Demonstrates Robust, Sustained Antidepressant Effects And Excellent Tolerability In Phase 2b Study 12/10/2014 7:41:02 AM
Biopharma Startup Naurex Inc. Scores $80 Million Series C Financing 12/3/2014 6:53:34 AM
Naurex Inc. Release: Data Presented At Society For Neuroscience Demonstrates That Naurex's GLYX-13 Enhances Synaptic Plasticity Through NMDA Receptor Modulation 11/17/2014 2:57:09 PM
Naurex Inc. To Present At UBS Global Healthcare Conference 5/15/2014 7:36:45 AM
123
//-->